Gastroesophageal Junction Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer [Phase 3]
Phase 3 study evaluating BBI608 plus weekly paclitaxel for gastric and gastroesophageal junction cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 trial evaluating conversion therapy with Camrelizumab plus chemoradiotherapy in patients with initially unresectable gastric or GEJ …
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers [Phase 2]
Phase 2 clinical trial evaluating toripalimab for recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma after failure …
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating andecaliximab with nivolumab vs nivolumab alone in unresectable or recurrent gastric or gastroesophageal junction a…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer [Phase 2, Phase 3]
A Phase 2/3 trial comparing FLOT with and without HER2-targeted therapy (Herceptin/Pertuzumab) as perioperative treatment for HER-2 expressi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma [Phase 1, Phase 2]
A Phase 1b/2 trial evaluating MEDI4736 (durvalumab) with tremelimumab, MEDI4736 alone, or tremelimumab alone in gastric or gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers [Phase 1]
A Phase 1 pilot study evaluating the safety and feasibility of adding FOLFIRINOX chemotherapy to neoadjuvant radiation for gastric and gastr…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. [Phase 2]
A Phase 2 clinical trial evaluating sintilimab in combination with Xelox as neoadjuvant therapy for resectable locally advanced gastric or g…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) [Phase 2]
Phase 2 trial evaluating preoperative chemotherapy and chemoradiotherapy for adenocarcinoma of the stomach and gastroesophageal junction has…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer [Phase 2]
Phase II study of ramucirumab in combination with chemotherapy for metastatic gastric/gastroesophageal junction cancer was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin, capecitabine, and trastuzumab with chemoradiotherapy as adjuvant therapy in operable HER2-positive gas…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma [Phase 2]
Phase 2 trial evaluating capecitabine, carboplatin, and bevacizumab for gastroesophageal junction and gastric cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer [Phase 2]
A phase 2 trial evaluating FDG-PET directed treatment for locally advanced gastric and gastroesophageal junction adenocarcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer [Phase 2]
Phase 2 trial assessing a chemotherapy combination (cisplatin-fluorouracil-afatinib) in patients with inoperable gastric or gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer [Phase 1, Phase 2]
Phase 1/2 study updates on ramucirumab plus nivolumab in gastric and GEJ cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating toripalimab with preoperative chemoradiotherapy for locally advanced esophagogastric junction cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 1, Phase 2]
A clinical trial evaluating gentuximab plus paclitaxel in advanced gastric or gastroesophageal junction cancer is in Phase 1/2 with status c…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating oxaliplatin, capecitabine (Xeloda), and cetuximab as first-line therapy for metastatic or unresectable gas…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. [Phase 2]
Phase II clinical trial evaluating CHFR methylation status in patients with metastatic esophageal, gastroesophageal, and gastric cancers; st…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial update for sorafenib in metastatic or recurrent esophageal and gastroesophageal junction cancer.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma [Phase 2]
A Phase 2 trial of Celecoxib in combination with Oxaliplatin and Capecitabine for gastric cancer and gastroesophageal junction cancer has be…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of docetaxel, oxaliplatin, and fluorouracil in patients with metastatic or unresectable stomach/gas…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery [Phase 2]
Phase 2 trial investigating regorafenib for locally advanced esophageal or gastroesophageal junction cancer after chemoradiation and surgery…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer [Phase 2]
A Phase 2 trial of preoperative dose-dense chemotherapy with weekly cisplatin, epirubicin and paclitaxel for locally advanced gastric cancer…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating a combination of capecitabine and oxaliplatin with radiation therapy for esophageal or gastroesophageal junction ca…